Henry Lu
Corporate Officer/Principal at WUXI APPTEC CO., LTD.
Profile
Henry Lu is currently the Vice President & Head-Biology at WuXi AppTec Co., Ltd.
Prior to this, he worked as the Senior Director-Infectious Diseases at Rigel Pharmaceuticals, Inc. and as a Principal Scientist at Novartis Corp.
He also served as an Adjunct Associate Professor at The University of California, San Francisco.
Dr. Lu received his undergraduate degree from Fudan University and his doctorate from Academia Sinica.
Henry Lu active positions
Companies | Position | Start |
---|---|---|
WUXI APPTEC CO., LTD. | Corporate Officer/Principal | 02/08/2011 |
Former positions of Henry Lu
Companies | Position | End |
---|---|---|
RIGEL PHARMACEUTICALS, INC. | Corporate Officer/Principal | - |
Novartis Corp.
Novartis Corp. Pharmaceuticals: MajorHealth Technology Novartis Corp. manufactures pharmaceuticals, vaccines, consumer health, generics, eye care and animal health products. It manufactures drugs for oncology, hypertension, diabetes, cancer and cardiovascular diseases. The company was founded on November 15, 1996 and is headquartered in New York, NY. | Corporate Officer/Principal | - |
The University of California, San Francisco | Corporate Officer/Principal | - |
Training of Henry Lu
Fudan University | Undergraduate Degree |
Academia Sinica | Doctorate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Listed companies | 2 |
---|---|
RIGEL PHARMACEUTICALS, INC. | Health Technology |
WUXI APPTEC CO., LTD. | Health Technology |
Private companies | 1 |
---|---|
Novartis Corp.
Novartis Corp. Pharmaceuticals: MajorHealth Technology Novartis Corp. manufactures pharmaceuticals, vaccines, consumer health, generics, eye care and animal health products. It manufactures drugs for oncology, hypertension, diabetes, cancer and cardiovascular diseases. The company was founded on November 15, 1996 and is headquartered in New York, NY. | Health Technology |
- Stock Market
- Insiders
- Henry Lu